Yuanyuan Zhang

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Chronic Myeloid Leukemia

Epithelial Mesenchymal Transition

Lipopolysaccharide Induced

Top Venues

Oxidative medicine and cellular longevity

The Journal of pharmacy and pharmacology

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Shuaishuai Gong, Jincheng Liu, Shiyao Wan, Weiwei Yang, Yuanyuan Zhang, Bo-Yang Yu, Fang Li, Jun-Ping Kou
Schisandrol A Attenuates Myocardial Ischemia/Reperfusion-Induced Myocardial Apoptosis through Upregulation of 14-3-3θ. Oxidative medicine and cellular longevity 2021 (2021)
Yuwei Wang, Lixuan Xue, Yunhao Wu, Jiazhi Zhang, Yujie Dai, Fang Li, Junping Kou, Yuanyuan Zhang
Ruscogenin attenuates sepsis-induced acute lung injury and pulmonary endothelial barrier dysfunction via TLR4/Src/p120-catenin/VE-cadherin signalling pathway. The Journal of pharmacy and pharmacology 73 (7) (2021)
Yuankai Liu, Yujie Dai, Han Xu, Qianliu Zhou, Fang Li, Boyang Yu, Yuanyuan Zhang, Jun-Ping Kou
YQFM Alleviates Side Effects Caused by Dasatinib through the ROCK/MLC Pathway in Mice. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)